share_log

T2 Biosystems | CORRESP: CORRESP

T2 Biosystems | CORRESP: CORRESP

T2 Biosystems | CORRESP:信函
美股SEC公告 ·  2024/07/27 01:36

Moomoo AI 已提取核心訊息

T2 Biosystems, Inc. has formally requested the Securities and Exchange Commission (SEC) to accelerate the effective date of its Registration Statement on Form S-3, initially filed on July 19, 2024. The company is seeking to have the registration statement become effective by 4:00 p.m. on July 29, 2024, or as soon as possible thereafter. This request was made under Rule 461(a) of the Securities Act of 1933, as amended. T2 Biosystems has asked to be notified of the registration statement's effectiveness via a phone call to their legal representative, N. Danny Shulman of Latham & Watkins LLP, and also to receive written confirmation.
T2 Biosystems, Inc. has formally requested the Securities and Exchange Commission (SEC) to accelerate the effective date of its Registration Statement on Form S-3, initially filed on July 19, 2024. The company is seeking to have the registration statement become effective by 4:00 p.m. on July 29, 2024, or as soon as possible thereafter. This request was made under Rule 461(a) of the Securities Act of 1933, as amended. T2 Biosystems has asked to be notified of the registration statement's effectiveness via a phone call to their legal representative, N. Danny Shulman of Latham & Watkins LLP, and also to receive written confirmation.
t2 biosystems公司正式要求美國證券交易所(SEC)加快其S-3表格的生效日期,該表格最初於2024年7月19日提交。公司希望該註冊表格在2024年7月29日下午4點或儘快在此之後生效。此請求是根據修正後的1933年證券法規則461(a)提出的。t2 biosystems公司要求通過電話通知其法律代表Latham & Watkins LLP的N. Danny Shulman,同時收到書面確認。
t2 biosystems公司正式要求美國證券交易所(SEC)加快其S-3表格的生效日期,該表格最初於2024年7月19日提交。公司希望該註冊表格在2024年7月29日下午4點或儘快在此之後生效。此請求是根據修正後的1933年證券法規則461(a)提出的。t2 biosystems公司要求通過電話通知其法律代表Latham & Watkins LLP的N. Danny Shulman,同時收到書面確認。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息